메뉴 건너뛰기




Volumn 152, Issue 1, 2011, Pages 4-10

Minireview: Fibroblast growth factor 23 in phosphate homeostasis and bone metabolism

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

EID: 78650833297     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0800     Document Type: Review
Times cited : (78)

References (63)
  • 1
    • 4744372082 scopus 로고    scopus 로고
    • Evolution of the Fgf and Fgfr gene families
    • Itoh N, Ornitz D M 2004 Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569
    • (2004) Trends Genet , vol.20 , pp. 563-569
    • Itoh, N.1    Ornitz, D.M.2
  • 2
    • 34250223124 scopus 로고    scopus 로고
    • Physiology. Sister act
    • Moore DD 2007 Physiology. Sister act. Science 316:1436-1438
    • (2007) Science , vol.316 , pp. 1436-1438
    • Moore, D.D.1
  • 3
    • 0033763097 scopus 로고    scopus 로고
    • Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
    • ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
    • (2000) Nat Genet , vol.26 , pp. 345-348
    • Consortium, A.1
  • 5
    • 0034703619 scopus 로고    scopus 로고
    • Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
    • Yamashita T, Yoshioka M, Itoh N 2000 Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494-498
    • (2000) Biochem Biophys Res Commun , vol.277 , pp. 494-498
    • Yamashita, T.1    Yoshioka, M.2    Itoh, N.3
  • 18
    • 0032865417 scopus 로고    scopus 로고
    • Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia
    • Fukumoto S, Takeuchi Y, Nagano A, Fujita T 1999 Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 25:375-377
    • (1999) Bone , vol.25 , pp. 375-377
    • Fukumoto, S.1    Takeuchi, Y.2    Nagano, A.3    Fujita, T.4
  • 20
    • 34147138937 scopus 로고    scopus 로고
    • PET/CT localizationofphosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia
    • Roarke M C, Nguyen B D 2007 PET/CT localizationofphosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 32:300-301
    • (2007) Clin Nucl Med , vol.32 , pp. 300-301
    • Roarke, M.C.1    Nguyen, B.D.2
  • 21
    • 77956313516 scopus 로고    scopus 로고
    • Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia
    • Ito N, Shimizu Y, Suzuki H, Saito T, Okamoto T, Hori M, Akahane M, Fukumoto S, Fujita T 2010 Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia. J Intern Med 268:390-394
    • (2010) J Intern Med , vol.268 , pp. 390-394
    • Ito, N.1    Shimizu, Y.2    Suzuki, H.3    Saito, T.4    Okamoto, T.5    Hori, M.6    Akahane, M.7    Fukumoto, S.8    Fujita, T.9
  • 23
    • 0029160578 scopus 로고
    • A gene (PEX) with homologies to en-dopeptidases is mutated in patients with X-linked hypophos-phatemic rickets
    • The HYP Consortium
    • The HYP Consortium 1995 A gene (PEX) with homologies to en-dopeptidases is mutated in patients with X-linked hypophos-phatemic rickets. Nat Genet 11:130-136
    • (1995) Nat Genet , vol.11 , pp. 130-136
  • 26
    • 9644303231 scopus 로고    scopus 로고
    • Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
    • Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421-432
    • (2004) Matrix Biol , vol.23 , pp. 421-432
    • Sitara, D.1    Razzaque, M.S.2    Hesse, M.3    Yoganathan, S.4    Taguchi, T.5    Erben, R.G.6    Jüppner, H.7    Lanske, B.8
  • 27
    • 18444375871 scopus 로고    scopus 로고
    • Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophos-phatemia in vivo
    • Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2002 Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophos-phatemia in vivo. Endocrinology 143:3179-3182
    • (2002) Endocrinology , vol.143 , pp. 3179-3182
    • Shimada, T.1    Muto, T.2    Urakawa, I.3    Yoneya, T.4    Yamazaki, Y.5    Okawa, K.6    Takeuchi, Y.7    Fujita, T.8    Fukumoto, S.9    Yamashita, T.10
  • 28
    • 0013118819 scopus 로고    scopus 로고
    • The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
    • Bai XY, Miao D, Goltzman D, Karaplis AC 2003 The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843-9849
    • (2003) J Biol Chem , vol.278 , pp. 9843-9849
    • Bai, X.Y.1    Miao, D.2    Goltzman, D.3    Karaplis, A.C.4
  • 29
    • 34249664523 scopus 로고    scopus 로고
    • FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets
    • Imel EA, Hui SL, Econs MJ 2007 FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22:520-526
    • (2007) J Bone Miner Res , vol.22 , pp. 520-526
    • Imel, E.A.1    Hui, S.L.2    Econs, M.J.3
  • 34
    • 76049105171 scopus 로고    scopus 로고
    • Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophos-phatemic rickets
    • Lorenz-Depiereux B, Schnabel D, Tiosano D, HäuslerG, Strom TM 2010 Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophos-phatemic rickets. Am J Hum Genet 86:267-272
    • (2010) Am J Hum Genet , vol.86 , pp. 267-272
    • Lorenz-Depiereux, B.1    Schnabel, D.2    Tiosano, D.3    Häusler, G.4    Strom, T.M.5
  • 35
    • 43149103153 scopus 로고    scopus 로고
    • Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: Proposal of diagnostic criteria using FGF23 measurement
    • Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsu-moto T 2008 Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235-1239
    • (2008) Bone , vol.42 , pp. 1235-1239
    • Endo, I.1    Fukumoto, S.2    Ozono, K.3    Namba, N.4    Tanaka, H.5    Inoue, D.6    Minagawa, M.7    Sugimoto, T.8    Yamauchi, M.9    Michigami, T.10    Matsu-Moto, T.11
  • 36
    • 16244364756 scopus 로고    scopus 로고
    • The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI)
    • Ruf N, Uhlenberg B, Terkeltaub R, Nurnberg P, Rutsch F 2005 The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI). Hum Mutat 25:98
    • (2005) Hum Mutat , vol.25 , pp. 98
    • Ruf, N.1    Uhlenberg, B.2    Terkeltaub, R.3    Nurnberg, P.4    Rutsch, F.5
  • 39
    • 0036829257 scopus 로고    scopus 로고
    • Bone mineralization in polyostotic fibrous dysplasia: Histomorphometric analysis
    • Terpstra L, Rauch F, Plotkin H, Travers R, Glorieux FH 2002 Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis. J Bone Miner Res 17:1949-1953
    • (2002) J Bone Miner Res , vol.17 , pp. 1949-1953
    • Terpstra, L.1    Rauch, F.2    Plotkin, H.3    Travers, R.4    Glorieux, F.H.5
  • 42
    • 77954424487 scopus 로고    scopus 로고
    • Elevated FGF-23 and parathormone in linear nevus sebaceous syndrome with resistant rickets
    • Sethi SK, Hari P, Bagga A 2010 Elevated FGF-23 and parathormone in linear nevus sebaceous syndrome with resistant rickets. Pediatr Nephrol 25:1577-1578
    • (2010) Pediatr Nephrol , vol.25 , pp. 1577-1578
    • Sethi, S.K.1    Hari, P.2    Bagga, A.3
  • 44
    • 68849127439 scopus 로고    scopus 로고
    • Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemia
    • Shimizu Y, Tada Y, Yamauchi M, Okamoto T, Suzuki H, Ito N, Fukumoto S, Sugimoto T, Fujita T 2009 Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 45:814-816
    • (2009) Bone , vol.45 , pp. 814-816
    • Shimizu, Y.1    Tada, Y.2    Yamauchi, M.3    Okamoto, T.4    Suzuki, H.5    Ito, N.6    Fukumoto, S.7    Sugimoto, T.8    Fujita, T.9
  • 45
    • 0023684611 scopus 로고
    • Correlations of serum concentrations of 1, 25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis
    • Lyles KW, Halsey DL, Friedman NE, Lobaugh B 1988 Correlations of serum concentrations of 1, 25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis. J Clin Endocrinol Metab 67:88-92
    • (1988) J Clin Endocrinol Metab , vol.67 , pp. 88-92
    • Lyles, K.W.1    Halsey, D.L.2    Friedman, N.E.3    Lobaugh, B.4
  • 49
    • 0037234565 scopus 로고    scopus 로고
    • All in the family: The UDP-Gal N Ac:polypeptide N- acetylgalactosaminyltransferases
    • Ten Hagen KG, Fritz TA, Tabak LA 2003 All in the family: the UDP-Gal N Ac:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13:1R-16R
    • (2003) Glycobiology , vol.13
    • Ten Hagen, K.G.1    Fritz, T.A.2    Tabak, L.A.3
  • 52
    • 13544270218 scopus 로고    scopus 로고
    • An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
    • Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B 2005 An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385-390
    • (2005) Hum Mol Genet , vol.14 , pp. 385-390
    • Benet-Pagès, A.1    Orlik, P.2    Strom, T.M.3    Lorenz-Depiereux, B.4
  • 54
    • 0141525564 scopus 로고    scopus 로고
    • Serum FGF23 levels in normal and disordered phosphorus homeostasis
    • Weber TJ, Liu S, Indridason OS, Quarles LD 2003 Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227-1234
    • (2003) J Bone Miner Res , vol.18 , pp. 1227-1234
    • Weber, T.J.1    Liu, S.2    Indridason, O.S.3    Quarles, L.D.4
  • 56
    • 0344945402 scopus 로고    scopus 로고
    • Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
    • Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272-2279
    • (2003) Kidney Int , vol.64 , pp. 2272-2279
    • Larsson, T.1    Nisbeth, U.2    Ljunggren, O.3    Jüppner, H.4    Jonsson, K.B.5
  • 57
    • 77649227621 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 and early decrements in kidney function: The Heart and Soul Study
    • Ix JH, Shlipak MG, Wassel CL, Whooley MA 2010 Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant 25:993-997
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 993-997
    • Ix, J.H.1    Shlipak, M.G.2    Wassel, C.L.3    Ma, W.4
  • 58
    • 27744545673 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
    • Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205-2215
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2205-2215
    • Gutierrez, O.1    Isakova, T.2    Rhee, E.3    Shah, A.4    Holmes, J.5    Collerone, G.6    Jüppner, H.7    Wolf, M.8
  • 62
    • 77957668094 scopus 로고    scopus 로고
    • FGF23: More than a regulator of renal phosphate handling?
    • Jüppner H, Wolf M, Salusky IB 2010 FGF23: more than a regulator of renal phosphate handling? J Bone Miner Res 25:2091-2097
    • (2010) J Bone Miner Res , vol.25 , pp. 2091-2097
    • Jüppner, H.1    Wolf, M.2    Salusky, I.B.3
  • 63
    • 77956539995 scopus 로고    scopus 로고
    • Forging forward with 10 burning questions on FGF23 in kidney disease
    • Wolf M 2010 Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21:1427-1435
    • (2010) J Am Soc Nephrol , vol.21 , pp. 1427-1435
    • Wolf, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.